In addition, Ibrahim et al. (2022) reported that the SGLT-2 inhibitor dapagliflozin directly phosphorylated LKB1, leading to increased hippocampal expression of p-AMPK in the ovariectomized/D-galactose rat model of Alzheimer’s disease. The gene discussed is SLC5A2; the disease is Alzheimer disease.